PRICE T ROWE ASSOCIATES INC /MD/
Position in FULC — Fulcrum Therapeutics, Inc.
CIK 80255
BALTIMORE, MD
Position in FULC
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$614,896
-$106,229 QoQ
Shares Held
80,169
+25.7% QoQ
Ownership
0.120%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#61
of 168 holders
Holding Since
Sep 2021
19 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in FULC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $13,950,986,356 across 255 Biotechnology names. FULC ranks #169 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
3,374,955 | $2,464,560,888 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,177,527 | $1,682,444,460 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,760,122 | $785,964,877 | |
| 4 | INSM |
INSMED Inc
|
3,092,807 | $505,735,799 | |
| 5 | KYMR |
Kymera Therapeutics, Inc.
|
6,060,847 | $504,807,946 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,432,748 | $474,053,330 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
3,232,213 | $314,332,713 | |
| 8 | SRRK |
Scholar Rock Holding Corp
|
6,206,618 | $305,117,340 |
All Filings in FULC
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $614,896 | 80,169 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $721,125 | 63,760 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $606,206 | 65,892 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $474,912 | 69,028 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $202,083 | 70,168 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $246,129 | 52,368 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $127,491 | 35,712 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $221,414 | 35,712 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $150,096 | 15,900 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $107,325 | 15,900 | Shares | Defined | 2024-02-16 | |
| 2023-09-30 | $70,596 | 15,900 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $69,960 | 21,200 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $103,913 | 36,461 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $1,095,705 | 150,509 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $360,854 | 44,605 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $145,613 | 29,717 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $596,098 | 25,205 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $2,383,815 | 134,755 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,252,524 | 44,400 | Shares | Sole | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||